Technical articles
4/10/2022
EU GMP Annex 1 update: what has changed, and what are the impacts?
EU GMP Annex 1 on good manufacturing practice defines rules for the manufacture of sterile medicinal products. Based on a 2008 ver
15/09/2022
AI for the detection of diseases – Image analysis
In recent years, artificial intelligence has played a prominent role in the area of health.Its booming use has to fulfil various t
21/03/2022
Focus on the propensity score
When you are implementing some of the studies managed by Soladis, you may need to calculate a “propensity score”.What
6/01/2022
Why is it important to precisely calculate sample sizes before carrying out studies?
Whether in clinical or industrial studies, numerous standards are emerging to justify sample sizes.This is the case, for example,
15/12/2021
Discovering our -omics activities
To demystify this area of activity and offer you the opportunity to better understand it, our biostatistics and bioinformatics -om
Join our team
Consult our offers
16/11/2021
Post-Market Surveillance (PMS), Post-Market Clinical Follow-up (PMCF/PMPF) and PMCF/PMPF Studies
Post-Market SurveillanceFor any MD (including IVDMDs) placed on the market, made available on the market or put into service, manu
27/07/2021
Data Integrity – The adventures continues
Why data integrity?Data are central to all our interactions, communications and strategic decision-making. In the pharmaceutical a
20/02/2020
Validation of analytical procedures according to the ICH guidelines
Since 1990, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has been
4/02/2020
New trends in medical journals: limited use of p-values in favour of estimated indicators and confidence intervals
Why is the p-value, once so widely used, now being called into question?
